Janus Henderson Investors is an investment management firm specializing in long-term financial management that is headquartered in Denver, Colorado and was founded in 2017 during the merger of Janus Capital Group and Henderson Global Investors. The firm offers a variety of financial products such as ETFs, managed accounts, and mutual funds that are focused on different asset classes such as alternatives, equities, fixed income, and multi-asset. The firms investment products have an investment focus on emerging markets, global, international, and United States markets.
Janus Henderson Investors also offers advisory services for client acquisition, client loyalty, team and personal effectiveness, fiduciary & regulatory, and portfolio strategy.
Magic Leap is an augmented reality company developing hardware and software for enhanced AR experience.
Decibel Therapeutics conducts inner ear research to deliver medicines for hearing and balance.
BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.
An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
4D Molecular Therapeutics designs, develops and commercializes products for gene therapy.
ALX Oncology is a Burlingame, California-based biotechnology company working on pre-clinical stage immuno-oncology therapies.
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation.
Akero Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on reversing the NASH epidemic by restoring the body's metabolism to a balanced state.
Cyteir Therapeutics is a Cambridge, Massachusetts-based company.
Rain Therapeutics is a Fremont, California-based company.
Chief Executive Officer